105 CMR 120.566
Training for Use of Manual Brachytherapy Sources
Except as provided in 105 CMR 120.528, the licensee shall require an authorized user of a
manual brachytherapy source for the uses authorized under 105 CMR 120.559 to be a physician
who:
(A) Is certified by a medical specialty board whose certification process has been recognized
by the Agency, an Agreement State or the Nuclear Regulatory Commission. The names of board
certifications that have been recognized by the Agency, Nuclear Regulatory Commission or an
Agreement State are posted on the NRC's Medical Uses Licensee Toolkit Web page. To have
its certification process recognized, a specialty board shall require all candidates for certification
to:
(1) Successfully complete a minimum of three years of residency training in a radiation
oncology program approved by the Residency Review Committee of the Accreditation
Council for Graduate Medical Education or the Royal College of Physicians and Surgeons
of Canada or the Committee on Post-Graduate Training of the American Osteopathic
Association; and
(2) Pass an examination, administered by diplomates of the specialty board, that tests
knowledge and competence in radiation safety, radionuclide handling, treatment planning,
quality assurance, and clinical use of manual brachytherapy; or
(B) (1) Has completed a structured educational program in basic radionuclide handling
techniques applicable to the use of manual brachytherapy sources that includes:
(a) 200 hours of classroom and laboratory training in the following areas:
1. Radiation physics and instrumentation;
2. Radiation protection;
3. Mathematics pertaining to the use and measurement of radioactivity; and,
4. Radiation biology; and
(b) 500 hours work experience, under the supervision of an authorized user who meets
the requirements in 105 CMR 120.528, 120.566 or equivalent Agreement State, or
Nuclear Regulatory Commission requirements at a medical facility authorized to use
byproduct materials under 105 CMR 120.559, involving:
1. Ordering, receiving, and unpacking radioactive materials safely and performing
the related radiation surveys;
2. Checking survey meters for proper operation;
3. Preparing, implanting, and removing brachytherapy sources;
4. Maintaining running inventories of material on hand;
5. Using administrative controls to prevent a medical event involving the use of
byproduct material;
6. Using emergency procedures to control byproduct material; and
(2) Has completed three years of supervised clinical experience in radiation oncology, under
an authorized user who meets the requirements in 105 CMR 120.528, 120.566 or equivalent
Agreement State or Nuclear Regulatory Commission requirements, as part of a formal
training program approved by the Residency Review Committee for Radiation Oncology of
the Accreditation Council for Graduate Medical Education or the Royal College of
Physicians and Surgeons of Canada or the Committee on Postdoctoral Training of the
American Osteopathic Association. This experience may be obtained concurrently with the
supervised work experience required by 105 CMR 120.566(B)(1)(b); and
(3) Has obtained written attestation that the individual has satisfactorily completed the
requirements in 105 CMR 120.566(B)(1) and (2) and is able to independently fulfill the
radiation safety-related duties as an authorized user of manual brachytherapy sources for the
medical uses authorized under 105 CMR 120.528. The attestation must be obtained from
either:
(a) A preceptor authorized user who meets the requirements in 105 CMR 120.528,
120.566, or equivalent Nuclear Regulatory Commission or Agreement State
requirements; or
(b) A residency program director who affirms in writing that the attestation represents
the consensus of the residency program faculty where at least one faculty member is an
authorized user who meets the requirements in 105 CMR 120.528, 120.566, or equivalent
Nuclear Regulatory Commission or Agreement State requirements, and concurs with the
attestation provided by the residency program director. The residency training program
must be approved by the Residency Review Committee of the Accreditation Council for
Graduate Medical Education or the Royal College of Physicians and Surgeons of Canada
or the Council on Postdoctoral Training of the American Osteopathic Association and
must include training and experience specified in 105 CMR 120.566(B)(1) and (2).